Cargando…

A systems genomics approach to uncover patient-specific pathogenic pathways and proteins in ulcerative colitis

We describe a precision medicine workflow, the integrated single nucleotide polymorphism network platform (iSNP), designed to determine the mechanisms by which SNPs affect cellular regulatory networks, and how SNP co-occurrences contribute to disease pathogenesis in ulcerative colitis (UC). Using SN...

Descripción completa

Detalles Bibliográficos
Autores principales: Brooks-Warburton, Johanne, Modos, Dezso, Sudhakar, Padhmanand, Madgwick, Matthew, Thomas, John P., Bohar, Balazs, Fazekas, David, Zoufir, Azedine, Kapuy, Orsolya, Szalay-Beko, Mate, Verstockt, Bram, Hall, Lindsay J., Watson, Alastair, Tremelling, Mark, Parkes, Miles, Vermeire, Severine, Bender, Andreas, Carding, Simon R., Korcsmaros, Tamas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051123/
https://www.ncbi.nlm.nih.gov/pubmed/35484353
http://dx.doi.org/10.1038/s41467-022-29998-8
_version_ 1784696495500427264
author Brooks-Warburton, Johanne
Modos, Dezso
Sudhakar, Padhmanand
Madgwick, Matthew
Thomas, John P.
Bohar, Balazs
Fazekas, David
Zoufir, Azedine
Kapuy, Orsolya
Szalay-Beko, Mate
Verstockt, Bram
Hall, Lindsay J.
Watson, Alastair
Tremelling, Mark
Parkes, Miles
Vermeire, Severine
Bender, Andreas
Carding, Simon R.
Korcsmaros, Tamas
author_facet Brooks-Warburton, Johanne
Modos, Dezso
Sudhakar, Padhmanand
Madgwick, Matthew
Thomas, John P.
Bohar, Balazs
Fazekas, David
Zoufir, Azedine
Kapuy, Orsolya
Szalay-Beko, Mate
Verstockt, Bram
Hall, Lindsay J.
Watson, Alastair
Tremelling, Mark
Parkes, Miles
Vermeire, Severine
Bender, Andreas
Carding, Simon R.
Korcsmaros, Tamas
author_sort Brooks-Warburton, Johanne
collection PubMed
description We describe a precision medicine workflow, the integrated single nucleotide polymorphism network platform (iSNP), designed to determine the mechanisms by which SNPs affect cellular regulatory networks, and how SNP co-occurrences contribute to disease pathogenesis in ulcerative colitis (UC). Using SNP profiles of 378 UC patients we map the regulatory effects of the SNPs to a human signalling network containing protein-protein, miRNA-mRNA and transcription factor binding interactions. With unsupervised clustering algorithms we group these patient-specific networks into four distinct clusters driven by PRKCB, HLA, SNAI1/CEBPB/PTPN1 and VEGFA/XPO5/POLH hubs. The pathway analysis identifies calcium homeostasis, wound healing and cell motility as key processes in UC pathogenesis. Using transcriptomic data from an independent patient cohort, with three complementary validation approaches focusing on the SNP-affected genes, the patient specific modules and affected functions, we confirm the regulatory impact of non-coding SNPs. iSNP identified regulatory effects for disease-associated non-coding SNPs, and by predicting the patient-specific pathogenic processes, we propose a systems-level way to stratify patients.
format Online
Article
Text
id pubmed-9051123
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-90511232022-04-30 A systems genomics approach to uncover patient-specific pathogenic pathways and proteins in ulcerative colitis Brooks-Warburton, Johanne Modos, Dezso Sudhakar, Padhmanand Madgwick, Matthew Thomas, John P. Bohar, Balazs Fazekas, David Zoufir, Azedine Kapuy, Orsolya Szalay-Beko, Mate Verstockt, Bram Hall, Lindsay J. Watson, Alastair Tremelling, Mark Parkes, Miles Vermeire, Severine Bender, Andreas Carding, Simon R. Korcsmaros, Tamas Nat Commun Article We describe a precision medicine workflow, the integrated single nucleotide polymorphism network platform (iSNP), designed to determine the mechanisms by which SNPs affect cellular regulatory networks, and how SNP co-occurrences contribute to disease pathogenesis in ulcerative colitis (UC). Using SNP profiles of 378 UC patients we map the regulatory effects of the SNPs to a human signalling network containing protein-protein, miRNA-mRNA and transcription factor binding interactions. With unsupervised clustering algorithms we group these patient-specific networks into four distinct clusters driven by PRKCB, HLA, SNAI1/CEBPB/PTPN1 and VEGFA/XPO5/POLH hubs. The pathway analysis identifies calcium homeostasis, wound healing and cell motility as key processes in UC pathogenesis. Using transcriptomic data from an independent patient cohort, with three complementary validation approaches focusing on the SNP-affected genes, the patient specific modules and affected functions, we confirm the regulatory impact of non-coding SNPs. iSNP identified regulatory effects for disease-associated non-coding SNPs, and by predicting the patient-specific pathogenic processes, we propose a systems-level way to stratify patients. Nature Publishing Group UK 2022-04-28 /pmc/articles/PMC9051123/ /pubmed/35484353 http://dx.doi.org/10.1038/s41467-022-29998-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Brooks-Warburton, Johanne
Modos, Dezso
Sudhakar, Padhmanand
Madgwick, Matthew
Thomas, John P.
Bohar, Balazs
Fazekas, David
Zoufir, Azedine
Kapuy, Orsolya
Szalay-Beko, Mate
Verstockt, Bram
Hall, Lindsay J.
Watson, Alastair
Tremelling, Mark
Parkes, Miles
Vermeire, Severine
Bender, Andreas
Carding, Simon R.
Korcsmaros, Tamas
A systems genomics approach to uncover patient-specific pathogenic pathways and proteins in ulcerative colitis
title A systems genomics approach to uncover patient-specific pathogenic pathways and proteins in ulcerative colitis
title_full A systems genomics approach to uncover patient-specific pathogenic pathways and proteins in ulcerative colitis
title_fullStr A systems genomics approach to uncover patient-specific pathogenic pathways and proteins in ulcerative colitis
title_full_unstemmed A systems genomics approach to uncover patient-specific pathogenic pathways and proteins in ulcerative colitis
title_short A systems genomics approach to uncover patient-specific pathogenic pathways and proteins in ulcerative colitis
title_sort systems genomics approach to uncover patient-specific pathogenic pathways and proteins in ulcerative colitis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051123/
https://www.ncbi.nlm.nih.gov/pubmed/35484353
http://dx.doi.org/10.1038/s41467-022-29998-8
work_keys_str_mv AT brookswarburtonjohanne asystemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT modosdezso asystemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT sudhakarpadhmanand asystemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT madgwickmatthew asystemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT thomasjohnp asystemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT boharbalazs asystemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT fazekasdavid asystemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT zoufirazedine asystemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT kapuyorsolya asystemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT szalaybekomate asystemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT verstocktbram asystemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT halllindsayj asystemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT watsonalastair asystemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT tremellingmark asystemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT parkesmiles asystemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT vermeireseverine asystemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT benderandreas asystemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT cardingsimonr asystemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT korcsmarostamas asystemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT brookswarburtonjohanne systemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT modosdezso systemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT sudhakarpadhmanand systemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT madgwickmatthew systemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT thomasjohnp systemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT boharbalazs systemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT fazekasdavid systemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT zoufirazedine systemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT kapuyorsolya systemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT szalaybekomate systemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT verstocktbram systemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT halllindsayj systemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT watsonalastair systemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT tremellingmark systemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT parkesmiles systemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT vermeireseverine systemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT benderandreas systemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT cardingsimonr systemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis
AT korcsmarostamas systemsgenomicsapproachtouncoverpatientspecificpathogenicpathwaysandproteinsinulcerativecolitis